VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
VSee Health (Nasdaq:VSEE) was featured on Bloomberg TV's RedChip Small Stocks, Big Money show. In the interview, co-CEO Imo Aisiku discussed the company's position in the $787 billion telehealth market. VSee's AI telehealth platform processes over 1.5M HIPAA-compliant video encounters monthly and has been deployed in over 50 countries. The company serves major clients including NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, and Qatar's healthcare system.
VSee Health (Nasdaq:VSEE) è stata ospite del programma RedChip Small Stocks, Big Money di Bloomberg TV. Nell'intervista, il co-CEO Imo Aisiku ha discusso della posizione dell'azienda nel mercato della telemedicina da 787 miliardi di dollari. La piattaforma di telemedicina AI di VSee gestisce oltre 1,5 milioni di incontri video conformi all'HIPAA ogni mese ed è stata implementata in più di 50 paesi. L'azienda serve clienti di spicco tra cui NASA, Dipartimento della Salute e dei Servizi Umani degli Stati Uniti, McKesson, Magellan, DaVita, GE e il sistema sanitario del Qatar.
VSee Health (Nasdaq:VSEE) fue presentado en el programa RedChip Small Stocks, Big Money de Bloomberg TV. En la entrevista, el co-CEO Imo Aisiku discutió la posición de la empresa en el mercado de telemedicina de 787 mil millones de dólares. La plataforma de telemedicina AI de VSee procesa más de 1.5 millones de encuentros de video cumplidores con HIPAA cada mes y ha sido implementada en más de 50 países. La empresa sirve a importantes clientes como NASA, el Departamento de Salud y Servicios Humanos de EE. UU., McKesson, Magellan, DaVita, GE y el sistema de salud de Qatar.
VSee Health (Nasdaq:VSEE)는 Bloomberg TV의 RedChip Small Stocks, Big Money 프로그램에 출연했습니다. 인터뷰에서 공동 CEO인 Imo Aisiku는 회사의 7870억 달러 규모의 원거리 의료 시장에서의 위치에 대해 논의했습니다. VSee의 AI 원거리 의료 플랫폼은 매월 150만 건 이상의 HIPAA 준수 비디오 만남을 처리하며, 50개 이상의 국가에서 적용되었습니다. 이 회사는 NASA, 미국 보건복지부, McKesson, Magellan, DaVita, GE 및 카타르의 의료 시스템을 포함한 주요 고객에게 서비스를 제공합니다.
VSee Health (Nasdaq:VSEE) a été présenté dans l'émission RedChip Small Stocks, Big Money de Bloomberg TV. Lors de l'interview, le co-CEO Imo Aisiku a discuté de la position de l'entreprise sur le marché de la télé santé de 787 milliards de dollars. La plateforme de télé santé AI de VSee traite plus de 1,5 million de rencontres vidéo conformes à la HIPAA chaque mois et a été déployée dans plus de 50 pays. L'entreprise sert de grands clients tels que la NASA, le Département de la Santé et des Services Sociaux des États-Unis, McKesson, Magellan, DaVita, GE et le système de santé du Qatar.
VSee Health (Nasdaq:VSEE) wurde in der Sendung RedChip Small Stocks, Big Money von Bloomberg TV vorgestellt. In dem Interview sprach Co-CEO Imo Aisiku über die Position des Unternehmens im 787 Milliarden Dollar umfassenden Telemedizinmarkt. Die AI-Telemedizin-Plattform von VSee verarbeitet monatlich über 1,5 Millionen HIPAA-konforme Video-Konversationen und wurde in über 50 Ländern eingesetzt. Das Unternehmen bedient namhafte Kunden wie NASA, das US-Gesundheitsministerium, McKesson, Magellan, DaVita, GE und das Gesundheitssystem von Katar.
- Platform handles 1.5M HIPAA-compliant video encounters monthly
- Established presence in over 50 countries
- Notable client portfolio including NASA, US HHS, McKesson, and Qatar
- Operating in $787 billion telehealth market
- None.
ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (Nasdaq:VSEE) and 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.
Access the interviews in their entirety at:
In an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the
Geoffrey Dow, CEO and President of 60 Degrees Pharmaceuticals, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company's mission to develop and commercialize new therapies for infectious diseases. He highlights the FDA-approved antimalarial drug ARAKODA® (tafenoquine) and outlines plans to expand its indications to address other diseases, including babesiosis. Dow also emphasizes the company's commitment to addressing unmet medical needs and improving global health outcomes.
VSee Health and 60 Degrees Pharmaceuticals are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About VSee Health
VSee Health's AI telehealth platform is the fastest way for enterprises to go from ideation to market go-live. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, its customizable telehealth building blocks each meet stringent security standards and are ready to scale. VSee Health has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA Space Station, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar.
VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. It is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. For more information, please visit www.vseehealth.com.
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases that affect the lives of millions of people. 60 Degrees Pharmaceuticals, Inc. achieved FDA approval of its lead product, ARAKODA® (tafenoquine), for malaria prevention, in 2018. 60 Degrees Pharmaceuticals, Inc. also collaborates with prominent research organizations in the U.S., Australia, and Singapore. The 60 Degrees Pharmaceuticals, Inc. mission has been supported through in-kind funding from the U.S. Department of Defense and private institutional investors including Knight Therapeutics Inc., a Canadian-based pan-American specialty pharmaceutical company. 60 Degrees Pharmaceuticals, Inc. is headquartered in Washington D.C., with a majority-owned subsidiary in Australia. Learn more at www.60degreespharma.com.
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 32 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com
--END--
SOURCE: RedChip
View the original press release on accesswire.com
FAQ
How many video encounters does VSee Health (VSEE) process monthly?
What is the market size for VSee Health's (VSEE) telehealth services?
Which major organizations are clients of VSee Health (VSEE)?
